 WATERTOWN, Mass.--BUSINESS WIRE--SQZ Biotechnologies NYSE: SQZ, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that it will present updates across three oncology programs at various stages of development. The data will be presented at the 36th Annual Meeting of the Society for Immunotherapy of Cancer SITC being held November 10-14, 2021, in Washington, D.C., and virtually. We are excited to share new preclinical data on our AAC a 